Company Product Description Indication Status

Eagle Pharmaceuticals Inc., of Woodcliff, N.J.

Ryanodex (dantrolene sodium)

Ryanodine receptor 1 antagonist

Exertional heat stroke

Company submitted a plan to the FDA to review data from all 41 patients from studies in 2015, 2018 and 2019

Lifemax Laboratories Inc., of Palo Alto, Calif.

LM-030

Kallikrein-related peptidase inhibitor

Netherton syndrome

European Commission granted orphan designation

Notes

For more information about individual companies and/or products, see Cortellis.

No Comments